• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov13
TD Cowen and H.C. Wainwright Maintain Buy Rating on Immunocore Holdings
22:52
Nov7
Immunocore Announces Encouraging Phase 1 Results for Hepatitis B Candidate IMC-I109V
13:00
Immunocore released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 295.54 M, actual EPS USD -0.1083
04:00
Immunocore released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 103.69 M (forecast USD 101.83 M), actual EPS USD -0.0035 (forecast USD -0.2475)
04:00
Aug7
Immunocore Presents Innovative Immune Modulating Drugs
13:55
Immunocore released FY2025 Semi-Annual earnings on August 7 Pre-Market EST, actual revenue USD 191.85 M, actual EPS USD -0.1051
13:30

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 103.69 M, Net Income -177 K, EPS -0.0035

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 97.96 M, Net Income -10.3 M, EPS -0.2047

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 93.88 M, Net Income 5.023 M, EPS 0.1

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy